Correlation Between Regeneron Pharmaceuticals and NORFOLK

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Regeneron Pharmaceuticals and NORFOLK at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Regeneron Pharmaceuticals and NORFOLK into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Regeneron Pharmaceuticals and NORFOLK SOUTHN P, you can compare the effects of market volatilities on Regeneron Pharmaceuticals and NORFOLK and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Regeneron Pharmaceuticals with a short position of NORFOLK. Check out your portfolio center. Please also check ongoing floating volatility patterns of Regeneron Pharmaceuticals and NORFOLK.

Diversification Opportunities for Regeneron Pharmaceuticals and NORFOLK

0.39
  Correlation Coefficient

Weak diversification

The 3 months correlation between Regeneron and NORFOLK is 0.39. Overlapping area represents the amount of risk that can be diversified away by holding Regeneron Pharmaceuticals and NORFOLK SOUTHN P in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on NORFOLK SOUTHN P and Regeneron Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Regeneron Pharmaceuticals are associated (or correlated) with NORFOLK. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of NORFOLK SOUTHN P has no effect on the direction of Regeneron Pharmaceuticals i.e., Regeneron Pharmaceuticals and NORFOLK go up and down completely randomly.

Pair Corralation between Regeneron Pharmaceuticals and NORFOLK

Given the investment horizon of 90 days Regeneron Pharmaceuticals is expected to under-perform the NORFOLK. In addition to that, Regeneron Pharmaceuticals is 1.8 times more volatile than NORFOLK SOUTHN P. It trades about -0.36 of its total potential returns per unit of risk. NORFOLK SOUTHN P is currently generating about -0.18 per unit of volatility. If you would invest  10,605  in NORFOLK SOUTHN P on September 12, 2024 and sell it today you would lose (680.00) from holding NORFOLK SOUTHN P or give up 6.41% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Weak
Accuracy57.81%
ValuesDaily Returns

Regeneron Pharmaceuticals  vs.  NORFOLK SOUTHN P

 Performance 
       Timeline  
Regeneron Pharmaceuticals 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Regeneron Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of inconsistent performance in the last few months, the Stock's technical and fundamental indicators remain very healthy which may send shares a bit higher in January 2025. The recent disarray may also be a sign of long period up-swing for the firm investors.
NORFOLK SOUTHN P 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days NORFOLK SOUTHN P has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest weak performance, the Bond's basic indicators remain strong and the current disturbance on Wall Street may also be a sign of long term gains for NORFOLK SOUTHN P investors.

Regeneron Pharmaceuticals and NORFOLK Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Regeneron Pharmaceuticals and NORFOLK

The main advantage of trading using opposite Regeneron Pharmaceuticals and NORFOLK positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Regeneron Pharmaceuticals position performs unexpectedly, NORFOLK can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in NORFOLK will offset losses from the drop in NORFOLK's long position.
The idea behind Regeneron Pharmaceuticals and NORFOLK SOUTHN P pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Technical Analysis module to check basic technical indicators and analysis based on most latest market data.

Other Complementary Tools

Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites